Cesca Therapeutics Inc. Announces Commercial Launch of AXP® II System for Advanced Cord Blood Processing
RANCHO CORDOVA, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the commercial launch of its AXP II …